|
| Status |
Public on Jul 06, 2018 |
| Title |
AHR ChIP-seq in lymphoblastoid cell line |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
ChIP-seq was done on one lymphoblastoid cell lines for vehicle control, or 3-MC agonist treatment to identify AHR binding regions throughout the genome. We identified 17,688 common binding peaks between all ChIP treatments
|
| |
|
| Overall design |
A lymphoblastoid cell line was treated in duplicate with vehicle control or 1uM 3-MC 24 hours before cells were collected for ChIP-seq. Sequencing was carried out on Illumina HiSeq 4000
|
| |
|
| Contributor(s) |
Weinshlboum RM, Neavin DR, Lee J, Ye Z, Wang L |
| Citation(s) |
31292129 |
| |
| Submission date |
Jul 05, 2018 |
| Last update date |
May 12, 2020 |
| Contact name |
Drew Neavin |
| E-mail(s) |
d.neavin@garvan.org.au
|
| Organization name |
Garvan Institute of Medical Research
|
| Department |
Cellular Science
|
| Street address |
384 Victoria St
|
| City |
Darlinghurst |
| State/province |
New South Wales |
| ZIP/Postal code |
2010 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
| Samples (6)
|
|
| This SubSeries is part of SuperSeries: |
| GSE116638 |
Role of AHR in lymphoblastoid cell lines |
|
| Relations |
| BioProject |
PRJNA479757 |
| SRA |
SRP152200 |
Less...
More...